Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Joshua D. Palmer"'
Gliosarcoma with PNET features mimicking a metastatic neuroendocrine carcinoma: A diagnostic dilemma
Autor:
Joshua D. Palmer, Nathaniel Toop, Spencer Ward, Dan Jones, Ben G McGahan, James B. Elder, Peter Kobalka
Publikováno v:
Clinical Neuropathology. 40:279-285
Objective Gliosarcomas (GS) comprise ~ 2 - 8% of glioblastomas and are associated with a similar poor prognosis. GS have rarely been found with a primitive neuroectodermal component (PNET). We present a case of gliosarcoma with PNET features (GS-PNET
Autor:
Jennifer K. Matsui, Haley K. Perlow, Benjin D. Facer, Aliah McCalla, Livia Marrazzo, Beatrice Detti, Marta Scorsetti, Elena Clerici, Silvia Scoccianti, Pierina Navarria, Daniel M. Trifiletti, Vinai Gondi, Joseph Bovi, Jiayi Huang, Paul D. Brown, Joshua D. Palmer
Publikováno v:
Chinese clinical oncology. 11(5)
Glioblastoma (GBM) is a disease with a poor prognosis. For decades, radiotherapy has played a critical role in the management of GBM. The standard of care radiation prescription is 60 Gy in 30 fractions, but landmark trials have historically excluded
Autor:
Eric J. Lehrer, Manmeet S. Ahluwalia, Jason Gurewitz, Kenneth Bernstein, Douglas Kondziolka, Ajay Niranjan, Zhishuo Wei, L. Dade Lunsford, Kareem R. Fakhoury, Chad G. Rusthoven, David Mathieu, Claire Trudel, Timothy D. Malouff, Henry Ruiz-Garcia, Phillip Bonney, Lindsay Hwang, Cheng Yu, Gabriel Zada, Samir Patel, Christopher P. Deibert, Piero Picozzi, Andrea Franzini, Luca Attuati, Rahul N. Prasad, Raju R. Raval, Joshua D. Palmer, Cheng-Chia Lee, Huai-Che Yang, Brianna M. Jones, Sheryl Green, Jason P. Sheehan, Daniel M. Trifiletti
Publikováno v:
Journal of neurosurgery.
OBJECTIVE Immune checkpoint inhibitors (ICIs) and stereotactic radiosurgery (SRS) are commonly utilized in the management of brain metastases. Treatment-related imaging changes (TRICs) are a frequently observed clinical manifestation and are commonly
Autor:
Kevin Liu, Dukagjin Blakaj, Prajwal Rajappa, Khaled Dibs, Haley K. Perlow, William Jiang, Raju Raval, Joshua D. Palmer
Publikováno v:
Neurosurgery Clinics of North America. 31:565-573
Whole-brain radiation therapy (WBRT) was frequently used to treat brain metastases in the past. Stereotactic radiosurgery (SRS) is now generally preferred to WBRT for patients with limited brain metastases. SRS can also be used to treat extensive bra
Autor:
Mueez Waqar, Federico Roncaroli, Eric J Lehrer, Joshua D Palmer, Javier Villanueva-Meyer, Steve Braunstein, Emma Hall, Marianne Aznar, Philip C De Witt Hamer, Pietro I D’Urso, Daniel Trifiletti, Alfredo Quiñones-Hinojosa, Pieter Wesseling, Gerben R Borst
Publikováno v:
Waqar, M, Roncaroli, F, Lehrer, E J, Palmer, J D, Villanueva-Meyer, J, Braunstein, S, Hall, E, Aznar, M, de Witt Hamer, P C, D'Urso, P I, Trifiletti, D, Quiñones-Hinojosa, A, Wesseling, P & Bors, G R 2022, ' Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor : Results from a systematic review and meta-analysis ', Neuro-oncology advances, vol. 4, no. 1, vdac075 . https://doi.org/10.1093/noajnl/vdac075
Neuro-oncology advances, vol 4, iss 1
Neuro-oncology advances, vol 4, iss 1
Background In patients with newly diagnosed glioblastoma, rapid early progression (REP) refers to tumor regrowth between surgery and postoperative chemoradiotherapy. This systematic review and meta-analysis appraised previously published data on REP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ba814b87fa901006830ac8c35b30b7b
https://research.vumc.nl/en/publications/32242781-305a-49fa-9019-458e6b16b018
https://research.vumc.nl/en/publications/32242781-305a-49fa-9019-458e6b16b018
Autor:
Yasmin Khakoo, Devang Pastakia, Rong Li, Asim K. Bag, Matthias A Karajannis, Sameer Farouk Sait, Karina Woodling, Stacie K. Totsch, Avi Madan-Swain, Diana S Osorio, James M. Johnston, Richard J. Whitley, John B. Fiveash, Gregory K. Friedman, Jeffrey R. Leonard, T. Prescott Atkinson, Li Nan, Kara Kachurak, Allison Martin, Joshua D. Palmer, Kyung-Don Kang, Joshua D. Bernstock, Rene McNall-Knapp, James M. Markert, Inmaculada Aban, G. Yancey Gillespie, Mohamed S. AbdelBaki, Charles Schlappi
Publikováno v:
The New England journal of medicine. 384(17)
Outcomes in children and adolescents with recurrent or progressive high-grade glioma are poor, with a historical median overall survival of 5.6 months. Pediatric high-grade gliomas are largely immunologically silent or "cold," with few tumor-infiltra
Publikováno v:
International Journal of Molecular Sciences. 23:2246
Gliomas represent a wide spectrum of brain tumors characterized by their high invasiveness, resistance to chemoradiotherapy, and both intratumoral and intertumoral heterogeneity. Recent advances in transomics studies revealed that enormous abnormalit
Autor:
Timothy D. Malouff, Danushka S. Seneviratne, Daniel M. Trifiletti, Cristopher Ramirez-Loera, Joshua D. Palmer, Henry Ruiz-Garcia
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 9673, p 9673 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 9673, p 9673 (2021)
Radiotherapy (RT) is one of the cornerstones in the current treatment paradigm for glioblastoma (GBM). However, little has changed in the management of GBM since the establishment of the current protocol in 2005, and the prognosis remains grim. Radio
Autor:
Nikol Mladkova, Joshua D. Palmer
Publikováno v:
Asian Pacific Journal of Cancer Care. 5:229-230
The COVID-19 global pandemic represents a unique challenge affecting all aspects of current life including the delivery of healthcare around the globe. Radiation treatment is an integral part in the management of many pediatric malignancies, and the
Autor:
Yinzhi Lai, Rita Axelrod, Maria Werner-Wasik, Charalambos C. Solomides, Zhong Ye, Jennifer Johnson, Boyd Hehn, Chun Wang, Ling Li, Voichita Bar-Ad, Bo Lu, Scott W. Cowan, Joshua D. Palmer, Nathaniel R. Evans, Ronald E. Myers
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 19(6)
Many studies recently focus on complicated and expensive genomic tests, but the prognostic values of biochemical markers which are easily obtained in clinics are largely overlooked and without further exploration. This study assesses the association